570 likes | 695 Views
Answering the Questions of Substance Exposure . Sandra Young, DNP, RNC . Healthy People 2010- Substance Exposure. Abstinence from Smoking During Pregnancy 99% Smoking Cessation During Pregnancy 30% Abstinence from Alcohol Use During Pregnancy 94%
E N D
Answering the Questions of Substance Exposure Sandra Young, DNP, RNC
Healthy People 2010- Substance Exposure • Abstinence from Smoking During Pregnancy 99% • Smoking Cessation During Pregnancy 30% • Abstinence from Alcohol Use During Pregnancy 94% • Goal to have 100% abstinence of illicit substance use during pregnancy
How bad is it? State statistics • 4.0 % of women pregnant and not pregnant (2006 MOD) (below national average 8.0 – 8.2%) • 114,000 used drugs in 2007 (National Survey on Drug Use and Health) • 21000 babies x 4.0 = 840 babies born substance exposed • 2010 18124 • The number of neonates treated for substance abuse tripled from 2003 to 2007, and was seven times greater in 2006 than 1999 • 816 mothers admitted to substance use from July 2007 to June 2008, 1501 mothers in 2010 • 103 babies required NICU level 3 care • $41,815 average cost • 16 day average LOS • Average cost of NICU care $1000/day
What is the Cost? • Baxter, Nerhood, and Chaffin (2008) • Forty-eight infants were diagnosed with NAS, with 40 (83.3%) requiring intensive care • total hospital costs $1.7 million • average cost of $36,700 • Medicaid paid 42% of cost in states 3 NICUs
A Blueprint to Improve West Virginia Perinatal Health Policy Recommendations to Improve Perinatal Health 1. Create a Coordinated Statewide Perinatal System 2. Save State Dollars by Reducing Costly Medical Procedures 3. Reduce Exposure to Tobacco Smoke During Pregnancy 4. Reduce Drug and Alcohol Use Among Pregnant Women 5. Improve Breastfeeding Support and Promotion 6. Improve Perinatal Health and Birth Outcomes of African American Women 7. Recruit and Retain More Obstetric Providers 8. Expand Newborn Screening to 29 Conditions 9. Encourage West Virginia Businesses to Offer Perinatal Worksite Wellness 10. Improve the Oral Health of Pregnant Women Through Policy and Education
Why is it a problem? • “Overwhelmed: WV Babies being turned away from intensive care” (Charleston Gazette, Nov. 2007) • Shortage of NICU Beds • Higher number of high risk infants delivered in rural hospitals • Increase in number of newborns requiring detoxification due to mother using drugs during pregnancy
What do we do? Caring for drug exposed infants can be emotionally, physically, and mentally demanding upon the nurse. Education may provide an understanding of the consequences of substance abuse on the newly born (Raeside, 2003)
What do we do? “Increased awareness of this growing problem is needed so that earlier interventions can be implemented” (Baxter, Nerhood, and Chaffin, 2008, p1).
When can substance use be identified? • Prenatal • Postpartum
Prenatal Screening • Prenatal Initiative • http://www.wvperinatal.org/downloads/committee_reports_07/Medical_Guidelines_2008.pdf • PRISI • http://www.wvdhhr.org/rfts/forms/R300_PRSIform_2.pdf • WV Healthy Start/HAPI project • Helping Appalachian Parents and Infants
When should you be more alert • Mother • No prenatal care • Late prenatal care • Limited prenatal care • Unanticipated delivery outside the birthing facility • Drop in delivery (Hospital/doctor hopping) • Abruptio placenta • Maternal admission to drug use during pregnancy • Positive Maternal drug screen
When should you be more alert • Infant • Unexplainable premature delivery • Unexplainable small for gestational age • Unexplainable small head circumference • Unexplained seizures, intracranial bleeds, or strokes • Unexplained symptoms that might suggest drug withdrawal: • High pitched crying, irritability, hypertonia, lethargy, disorganized sleep, sneezing, hiccoughs, drooling, diarrhea, feeding problems, or respiratory distress. • Unexplained congenital malformations involving genitourinary tract, abdominal wall or gastrointestinal systems
How is substance use identified • Meconium • Urine • Cord Blood • Hair • Umbilical Cord
What did the leaders say? How do you identify drugs of abuse in pregnant women? • Personal Report 76.2% • Blood Test 28.6% • Urine Test 76.2% • Other 4.8% • Prenatal Record
What did OB leaders say about substance use in WV? • What do you perceive to be the most common drug exposure in your neonate population? • Methamphetamine 15% • Cocaine 30% • Marijuana 85% • Opiates 35% • Poly substance abuse 5% • Other 30% • Methadone • Cigarettes • Barbiturates in addition to those mentioned • Benzos
What substances are most frequently used? • From July 2007 to June 2008 • 816 or 5% reported drug or alcohol use during pregnancy. • 489 (59%) reported using marijuana, • 143 methadone • 110 cocaine • 29 methamphetamine • 22 heroin • Alcohol use during pregnancy was reported by 185 mothers. • Poly-substance use was also identified, with 117 mothers admitting to poly-substance use (Tolliver, 2008).
2010 • 172 alcohol <1% • 75 cocaine <1% • 669 marijuana 3.6% • 231 methadone 1.3% • 30 heroin <1% • 50 methamphetamine <1% • 446 other opioids 2.4% • 1501 drugs 8.3% • Total 9.2%
What are the effects of these substances? • Marijuana • Cocaine • Methamphetamine • Opiates, Methadone, Heroin
Marijuana • Most commonly used substance after tobacco • CNS depressant • crosses the placenta and can cause reduction in the heart rate of the fetus • urine the first day of life and up to 3 days after delivery in meconium
Marijuana and Delivery Issues • Late prenatal care (Burns, et al., 2006) • More often required NICU admission
Marijuana • Alters neurobehavioral performance (Carvalho do Moraes Barros, et al., 2006) • Lower gestational age at delivery • Increased risk of prematurity (Sherwood, et al., 1999) • Reduction in the heart rate of the fetus (Schaefer, Peters, and Miller, 2007). • Growth Reduction
Marijuana Possible post-natal symptoms • Irritability • Tremors • Sleep disturbances • Jitteriness
Marijuana • Long term outcomes • increased risk of childhood leukemia and eye problems, as well as a link to developmental delays (D’Apolito, 1998). • increased risk of neuroblastoma in children when mothers use illicit or recreational drugs, particularly when marijuana is used in the first trimester of pregnancy. Bluhm, et al., (2006) • First trimester exposure to marijuana affected child’s depression and anxiety symptoms. Second trimester affected reading comprehension and underachievement. Goldschmidt, et al., 2004 • Speech and thought impairments
Marijuana and Breastfeeding • Passes into breast milk • Half life up to 57 hours • Exposure to marijuana in breast milk has been linked to delayed motor development • Breastfeeding with marijuana use should be discouraged
Cocaine • Most widely studied substance of abuse in pregnancy • CNS Stimulant • Causes vasoconstriction • Fetal, uterine and maternal • Resulting in infarcts and hemorrhages • Placenta appears to block some cocaine absorption • Cocaine can be present in neonatal urine for 1-2 days and meconium for up to 3 days following maternal ingestion
Cocaine and Delivery Issues • Placental abruption (Ananth,et al., 2006) • Premature ROM (Addis, etal., 2001) • Pre term labor • Less/late prenatal care (Fajemirokin-Odudeyi, et al., 2004) • Premature Delivery/prematurity • High risk of maternal death from intracerebral hemorrhage • Stillbirth • High risk of perinatal HIV • Higher risk of syphilis
Cocaine • Impact on the neonate • Delayed auditory brainstem response • Low birth weight (Bateman, et al., 1993) • Lower length • Lower head circumference (Bauer, et al., 2005) • IUGR • Abnormal fetal monitoring and circulatory issues • Higher heart rates (Schuetze and Eiden, (2006) • Higher incidence of hypertension (Shankaran, et al., 2006)
Cocaine • Meconium staining • Malformations • Urogenital • Brain • Midline deformities • Skull defects, encephaloceles • Ocular malformations • Vascular disruptions, such as limb reduction and intestinal atresia • Cardiac
Cocaine • Neurodevelopmental • Hypertonia • Tremors • Strokes • Seizures • Brainstem conduction relays
Cocaine Possible Post-natal Effects • Tremors and jitters (Bauer, et al., 2005) • High pitched cry • Excessive sucking • Possible Seizures • Tachycardia • Tachypnea • Apnea • Hyperirritability (may occur as late as 30 days after birth)
Cocaine • Long term issues • Higher infection rates • Negative behavioral outcomes at 3, 5 and 7 year follow-up (Bada, et al., 2007) • Lower IQ scores • Higher risk of SIDS
Cocaine and Breastfeeding • Appears in breast milk within 15 minutes of absorption • Half life less than ½ hour • Clears from breast milk within 5 hours • A cocaine-using, breastfeeding mother should pump and discard breast milk for 24 hours after cocaine use. Ideally abstaining from cocaine would be the first choice. Habitual cocaine users should avoid breastfeeding
Methamphetamine • Least studied substance of abuse • CNS Stimulant • Causes vasoconstriction • Placenta • Fetal organs • more likely to have APGAR scores of <7 (Ludlow, et al., 2004). • likely to be small for gestational age (SGA). • Administration of Narcan to a methamphetamine exposed neonate could result in the seizure activity.
Methamphetamine and Delivery Issues • Higher incidence of stillbirth • Poor prenatal care • Sexually transmitted diseases • Placental Abruption • Postpartum hemorrhage
Methamphetamine • Signs of exposure • hyperexcitability, • disturbances in muscle tone, • Cardiac Defects “Transposition of great vessels” • Cleft Lip • Biliary Atresia
Methamphetamine Possible Post-natal Symptoms • Tremors and jitters (Bauer, et al., 2005) • High pitched cry • Excessive sucking • Possible Seizures • Tachycardia • Tachypnea • Apnea • Hyperirritability (may occur as late as 30 days after birth)
Methamphetamine • Long term outcomes • Mothers have lower quality of life perceptions • Greater likelihood of substance use in family and social system • Increased risk for ongoing legal difficulties • Increased likelihood of development of a substance abuse disorder (Derauf, et al., 2007) • Potential for the following issues: • Respiratory Illnesses • Ingestion • Rashes • Burns
Methamphetamine and Breastfeeding • Passes into breast milk • Half life unknown • Breastfeeding with methamphetamine should be discouraged
Opiates • Opiates • Morphine • Heroin • Methadone • Demerol/ Meperidine • Codeine
Opiates • More likely to require resuscitation (Ludlow, et al, 2004) • APGAR scores methadone exposed equivalent to those neonates not exposed to opiates • More feeding problems (LaGasse, et al., 2002) • Higher rates of prematurity, SGA,(Martinez, Partridge, and Taeusch, 2005)
Opiates and Delivery Issues • Late prenatal care (Burns, et al., 2006) • More often require NICU admission • Antepartum hemorrhage • Increased risk of HIV (if mother an intravenous heroin user) • More likely to require resuscitation (Ludlow, et al, 2004) • Higher incidence of placental abruption • Higher incidence of premature delivery, preterm labor • Higher incidence of chorioamnionitis • Higher rates of meconium staining
Opiates • Higher incidence of SIDS
Opiates and Breastfeeding • All opiates pass into breast milk • Heroin using mothers should not breast feed • Methadone appears to be well tolerated in breast milk as there appears to be minimal transfer into breast milk • Breastfed babies of methadone using mothers have less symptoms of withdrawal and the need for medication treatment (AAP and Jansson, et al, 2008)
Neonatal Abstinence Syndrome(NAS) • Lifshitz, et al., (2001) found that 96% of neonates exposed in-utero to narcotics exhibited NAS. • Symptoms appear on average at 72 hours • May not appear for a long as 4 weeks
Symptoms of Neonatal Abstinence Syndrome • Central Nervous System Dysfunction • Irritability • Excessive Crying • Jitteriness • Tremulousness • Hyperactive reflexes • Increased tone • Sleep disturbance • Seizures
Neonatal Abstinence Syndrome • Autonomic Dysfunction • Excessive sweating • Mottling • Hyperthermia • Hypertension • Respiratory Symptoms • Tachypnea (rapid breathing) • Nasal stuffiness
Neonatal Abstinence Syndrome • Gastrointestinal and feeding disturbances • Diarrhea • Excessive Sucking • Hyperphagia (eating too much)
How do we determine withdrawal • Do you use an abstinence/withdrawal scoring tool on your neonates? • NO 57.1% • Yes 23.7% • Neonatal Abstinence Scale 14.3% • Finnegan 14.3% • Modified scale 9.5% • Other 14.3% • CAMC • Johns Hopkins/Bayview • Use risk assessment to determine who needs tested
Assessment Tools • http://www.rch.org.au/nets/handbook/media/NASS_1.pdf